U.S. Bans Imports From Three Chinese Biotech Companies Over Forced-Labor Allegations
The U.S. has banned imports from three Chinese biotech companies, citing allegations of forced labor in China's Xinjiang region.
Lafayette, LA, October 28, 2026 —
The United States has banned imports from three Chinese biotechnology companies, citing allegations of forced labor in China’s Xinjiang region. The information provided does not identify the companies or specify when the bans took effect.
The announcement also does not detail which goods are covered, how the restrictions will be enforced, or what evidence underlies the allegations. It does not name the U.S. agency responsible for the action or describe whether the companies have responded.
The stated basis for the import bans is allegations of forced labor in Xinjiang. No further information was provided about the alleged practices, the companies’ operations in the region, or any findings made by U.S. authorities. The allegations should therefore not be treated as independently established facts based on the available information.
The scope of the action remains unclear from the summary: it does not say whether the restrictions apply to all imports from the three companies or to particular products or shipments. It also provides no details about the duration of the bans or any process for review or appeal.
Further details, including the names of the companies, the products affected and the government’s supporting explanation, were not provided. Without those specifics, the immediate commercial impact and the precise reach of the restrictions cannot be determined.
Story summarized from the original created by DIDI TANG, Associated Press on www.klfy.com, see more information here.
Media gallery
